Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Topotecan in Patients With Brain Metastases
2006-004084-66Phase 2Active
- Sponsor
- Oncology Institute of Bari
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in brain metastases, sponsored by Oncology Institute of Bari. Primary endpoints: Objective response in brain metastases, Time to progression and 1 more. Started Jun 2007; status: active.
02
Drugs
topotecan
03
Conditions
brain metastases
Beyond the preview
Go deeper on 2006-004084-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004084-66.